Please ensure Javascript is enabled for purposes of website accessibility

2 Great Income Stocks to Buy Right Now

By David Jagielski - May 27, 2021 at 6:35AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

You won't be paying much of a premium for either of these dividend stocks.

If you are looking to make the most of an investment, you should consider stocks that have promising businesses, aren't overpriced, and that pay a decent yield. While that makes for a list of lofty requirements, being picky when it comes to which stocks you put in your portfolio can pay off handsomely and help you outperform the market.

Two stocks that tick off all those boxes today are Amgen (AMGN -0.25%) and Cisco Systems (CSCO -0.23%). Here's a look at why investing in these companies can set you up for some great returns down the road.

A couple counting money.

Image source: Getty Images.

1. Amgen

There's a lot to like about Amgen. The drugmaker has more than doubled its dividend payments from the $0.79 that it was paying back in 2015 to quarterly payout of $1.76 today. Its current yield of 2.8% is well above the S&P 500 average of 1.4% and can be an excellent source of cash flow for investors. Amgen currently maintains a 54% payout ratio, so there is plenty of room for the business to continue increasing its payments to shareholders.

The company is coming off a tough first quarter in which sales of $5.9 billion for the period ending March 31 declined by 4.2% from last year. Amgen blames the disappointing numbers on COVID-19, but the company sees some light at the end of the tunnel as vaccination rates climb higher. Despite its broader struggles, multiple drugs generated double-digit growth during the period, including Repatha (for high cholesterol) and Prolia (for bone loss). Although the company still anticipates some disruption during the second quarter, it sees that lessening in the latter half of the year as patient visits and diagnoses slowly return to pre-pandemic levels. In total, the company's profit of $1.6 billion in the first quarter was down 9.8% year over year when it released the results on April 27.

With shares of the healthcare stock up just 7% over the past year and vastly underperforming the S&P 500 and its 41% gains during that time, now may be a great time to load up on shares of Amgen. Trading at a forward price-to-earnings (P/E) ratio of less than 15, the stock isn't terribly expensive; investors are paying more than 23 times future earnings for both Eli Lilly and Abbott Laboratories

2. Cisco

Tech company Cisco pays investors a similar dividend yield of around 2.8%. And while its payouts haven't risen nearly as impressively as Amgen's have, with quarterly payments of $0.37, its shareholders are earning 76% more than they were in 2016 when Cisco was paying just $0.21 each quarter. Its payout ratio of 60% is slightly higher, but it's still low enough that investors don't need to lose sleep over its ability to reward shareholders.

The company released its third-quarter results on May 19, posting sales of $12.8 billion, which grew 6.8% year over year. It anticipates that in the fourth quarter, its growth rate will remain the same, expecting between 6% and 8%. Cisco also says demand is the strongest it has been in almost a decade. I'm optimistic that things will only get stronger, because as people continue to work remotely, there will be an incentive for businesses to upgrade their existing IT infrastructure. According to cybersecurity company Group-IB, ransomware attacks were up 150% in 2020. The extortion amounts grew in size and companies were down for an average of 18 days. The Colonial Pipeline breach is only the most recent popular example, which had devastating effects as it led to fuel shortages in parts of the country.

Cisco has also underperformed the markets the past year, rising by just 19%. Its forward P/E of 16 is lower than Oracle's multiple of 18 and is well below industry giant Microsoft, which is trading at 32 times its future earnings. Like Amgen, Cisco offers investors some promising growth opportunities, a decent valuation, and an above-average yield, making it a solid income stock to add to your portfolio today.

Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool's board of directors. David Jagielski has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Microsoft. The Motley Fool recommends Amgen. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Amgen Inc. Stock Quote
Amgen Inc.
AMGN
$250.58 (-0.25%) $0.63
Cisco Systems, Inc. Stock Quote
Cisco Systems, Inc.
CSCO
$46.66 (-0.23%) $0.11
Microsoft Corporation Stock Quote
Microsoft Corporation
MSFT
$291.32 (-0.26%) $0.77
Eli Lilly and Company Stock Quote
Eli Lilly and Company
LLY
$316.82 (2.10%) $6.51
Oracle Corporation Stock Quote
Oracle Corporation
ORCL
$79.25 (-0.34%) $0.27
Abbott Laboratories Stock Quote
Abbott Laboratories
ABT
$110.55 (-1.32%) $-1.48

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
402%
 
S&P 500 Returns
129%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/17/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.